期刊文献+

案例教学法在我院门诊超说明书用药教学中的应用探索

Exploration of Application of Case-Based Learning Method in Teaching of Off-label Drug Use in Our Outpatient
原文传递
导出
摘要 目的探讨案例教学法在我院门诊超说明书用药教学中的应用效果。方法引入1例门诊超说明书用药患者的案例,引导学生思考案例的特点,并通过分析我院风湿免疫科门诊超说明书用药的情况,了解超说明书用药的现状和管理策略。结果通过本次案例教学实践,学生在掌握风湿免疫科超说明书用药基础的知识的同时,加深了临床实际应用的理解,同时培养了临床药物治疗的思维方式。结论案例教学法是一种医院药师教学的有效方法。 OBJECTIVE To explore the effect of case-based learning method in teaching of off-label drug use in our outpatient. METHODS One case of off-label drug use in outpatient was introduced to guide the students to think about the clinical characteristics of the case,and then the situation of off-label drug use in rheumatoid arthritis patients was analyzed, and the prescriptions were managed by hierarchical management. RESULTS Through this case teaching practice,the students mastered the theoretical knowledge of off-label drug use and treatment of rheumatoid arthritis,deepened the understanding of clinical application of rheumatoid arthritis drugs,and cultivated the thinking mode of clinical pharmacotherapy. CONCLUSION Case-based learning method is an effective method and suitable for hospital pharmacist teaching.
作者 陈宁 杨学文 李锦 甄健存 CHEN Ning;YANG Xue-wen;LI Jin;ZHEN Jian-cun(Department of Pharmacy,Beijing Jishuitan Hospital,Beijing 100035,China)
机构地区 北京积水潭医院
出处 《中国药学杂志》 CAS CSCD 北大核心 2021年第3期241-243,共3页 Chinese Pharmaceutical Journal
关键词 案例教学法 超说明书用药 分级管理 case based learning method off-label drug use hierarchical management
  • 相关文献

参考文献5

二级参考文献46

  • 1中国药典.二部[S].2010:附录196.
  • 2广东省药学会.关于印发《药品未注册用法专家共识》的通知[J].(http://zwgk.gd.gov.cn/00694124X/201107/t20110701_191813.html).
  • 3Ferraz MB, Tugwell P, Goldsmith CH, et al.Meta-analysis of sulfasalazine in ankylosing spondylitis[J].J Rheumatol, 1990, 17(11):1482-1486.
  • 4Chen J, Liu C. Sulfasalazine for ankylosing spondylitis [J]. Cochrane Database Syst Rev , 2005, (2): CD004800.
  • 5Braun J, Haibel H, Hammer M, et al. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis:a multicentre randomised controlled trial[J].Ann Rheum Dis, 2006.65(9): 1147-1153.
  • 6Weinblatt ME, Reda D, Henderson W, et al.Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials[J]. J Rheumatol, 1999, 26(10):2123- 2130.
  • 7Gutierrez- Rodriguez O, Starusta- Baeal, P and Gutierrez- Montes, O. Starusta-Bacal and O. Gutierrez-Montes, Treatment of refractory rheumatoid arthritis:the thalidomide experience[J]. JRheumatol, 1989, 16(2); 158-163.
  • 8Lehman TJ, Striegel KH, Onel KB. Striegel and K.B. Onel, Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis[J].J Pediatr, 2002, 140(1): 125-127.
  • 9vedathamuryudan MD, Cemmat MD, Sebahattinsaip MD, et al. Thalidomide in the treatment of the mucocutaneous lesions of the behcet syndrome:a randomized, double- blind, placebo-controlled trial[J]. Ann Intern Med, 1998,128(6):443-450.
  • 10Visser K, Katchamart WL.Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative[J]. Ann Rheum Dis, 2009,68(7): 1086-1093.

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部